Viewing Study NCT07225361


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2026-03-08 @ 6:55 PM
Study NCT ID: NCT07225361
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-10-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Sponsor:
Organization: